Abstracts

COVID-19 VACCINATION IN PERSONS WITH AND WITHOUT HIV: VETERANS AGING COHORT STUDY

Background: COVID-19 vaccination is effective at preventing symptomatic infection, hospitalization, and death from COVID-19, but many people have experienced barriers to receiving this life preserving intervention. A study examining COVID-19 vaccination in New York state found that persons with HIV (PWH) were less likely to be vaccinated than the general population. We examined whether PWH…

HIV AND CHRONIC COMORBIDITIES: MEDICATION ADHERENCE AND CLINICAL ENDPOINT COVARIATION

Background: Evidence suggests negative monthly medication adherence trends during the COVID-19 era for patients with HIV (PWH) and multiple chronic conditions. However, it is unknown whether observed trends are associated with changes in outcomes of HIV care before and during the COVID-19 era. Methods: Adult PWH with type 2 diabetes, hypertension, and/or hypercholesterolemia were identified…

HIGH PREDICTED bNAb RESISTANCE AMONG ADULTS WITH HIV-1 SEROCONVERSION IN BOTSWANA

Background: We used proviral HIV-1C sequences from adults with documented HIV-1 seroconversion in Botswana, to determine HIV drug resistance mutations and predict (in silico) resistance to 33 known broadly neutralizing antibodies (bNAbs). Methods: We analyzed proviral sequences from adults with documented HIV-1 seroconversion (N&#3f140) from a population-based household study (Botswana Combination Prevention Project, 2013-2018). HIV-1C…

EFFECTIVENESS OF DOLUTEGRAVIR IN PEOPLE ON RIFAMPIN-BASED TUBERCULOSIS TREATMENT

Background: Tenofovir-lamivudine-dolutegravir (TLD) is the WHO-preferred first-line regimen for people with HIV, but drug-drug interactions between dolutegravir (DTG) and rifampin (RIF) require an additional 50mg DTG (TLD+50) in people receiving tuberculosis (TB)/HIV co-treatment. RIF is a key drug in TB treatment, but is a potent inducer of metabolizing enzymes and efflux transporters, which can markedly…

A MULTICENTER STUDY OF COVID-19 INFECTION IN PEDIATRIC INTENSIVE CARE UNITS IN THE US

Background: To describe characteristics of COVID-19 infection among patients requiring admission to pediatric intensive care units (PICU) in the USA. Methods: Observational surveillance study of COVID-19 infected patients admitted to PICUs in 27 US states between April 1, 2020 – May 1, 2021. Results: Four hundred fifty-three patients were included; the majority were from institutions…

VITAMIN C DYSREGULATION IN HIV: CROSS-SECTIONAL STUDY OF RENAL LEAK IN HIV+ WOMEN

Background: Reduced plasma vitamin C (vitC) concentrations in chronic diseases may result from abnormal urinary excretion of vitC: a renal leak. While low plasma vitC concentrations may be due to inadequate diet, vitC renal leak indicates underlying pathophysiology. Relationships between HIV+ status, renal leak, and plasma vitC concentrations are unknown. We investigated the prevalence and…

SARS-CoV-2 VARIANTS-DEPENDENT INFLAMMASOME ACTIVATION

Background: Innate immunity is the first line of defense in response to pathogens, which acts locally and also leads the stimulation of adaptive immunity through at least with IL-1β secretion. It has been shown that SARS-CoV-2 infection triggered the NLRP-3 inflammasome activation and the IL-1β secretion. The aim of this study was to analyze and…